Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Neoplasm Recurrence, Local (radionuclide imaging) - Ovarian Neoplasms (radionuclide imaging)

Terms

10Neoplasm Recurrence, Local (radionuclide imaging)
7Ovarian Neoplasms (radionuclide imaging)
3Ovarian Neoplasms (pathology)
9Adenocarcinoma (radionuclide imaging)
11Colorectal Neoplasms (radionuclide imaging)
11Radioimmunodetection
4Antibodies, Bispecific (diagnostic use)
18Carcinoembryonic Antigen (immunology)

Associations

Freq.WeightAssociation
60.717Neoplasm Recurrence, Local (radionuclide imaging) - Ovarian Neoplasms (radionuclide imaging)
30.655Ovarian Neoplasms (pathology) - Ovarian Neoplasms (radionuclide imaging)
70.704Adenocarcinoma (radionuclide imaging) - Colorectal Neoplasms (radionuclide imaging)
60.572Colorectal Neoplasms (radionuclide imaging) - Neoplasm Recurrence, Local (radionuclide imaging)
30.548Neoplasm Recurrence, Local (radionuclide imaging) - Ovarian Neoplasms (pathology)
30.522Ovarian Neoplasms (pathology) - Radioimmunodetection
60.471Adenocarcinoma (radionuclide imaging) - Carcinoembryonic Antigen (immunology)
40.471Antibodies, Bispecific (diagnostic use) - Carcinoembryonic Antigen (immunology)
40.456Ovarian Neoplasms (radionuclide imaging) - Radioimmunodetection
60.426Carcinoembryonic Antigen (immunology) - Colorectal Neoplasms (radionuclide imaging)
40.422Adenocarcinoma (radionuclide imaging) - Neoplasm Recurrence, Local (radionuclide imaging)
40.381Neoplasm Recurrence, Local (radionuclide imaging) - Radioimmunodetection

Documents par ordre de pertinence
000183 (1997) J P Vuillez (France) ; E Levrot ; M Mousseau ; P D Buffaz ; M Bolla ; R Payan ; M Comet ; R Schaerer[Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
000198 (1996) A Faivre-Chauvet (France) ; R C Mease ; A Chetanneau ; M Bardiès ; C Sai-Maurel ; G E Meinken ; S C Srivastava ; J F Chatal ; J F GestinPre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
000253 (1992) A Loboguerrero (France) ; C Pérault ; J C LiehnVolume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking.
000255 (1992) J C Liehn (France) ; A Loboguerrero ; C Pérault ; L DemangeSuperimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.
000084 (2007) A Sézeur (France) ; F P Châtelet ; Ch Cywiner ; Cl de Labriolle-Vaylet ; C Chastang ; Cl Billotey ; M Malafosse ; D Gallot ; P Betton ; F Montravers ; S Carvajal-Gonzalez ; S Askienazy ; J N Talbot ; J D Rain ; G Milhaud ; G Saumon ; J Barbet ; A Gruaz-GuyonPathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging.
000289 (1989) A Chetanneau (France) ; P A Lehur ; D Ripoche ; P Peltier ; J C Saccavini ; J P Vuillez ; N Tournemaine ; P Thedrez ; J F ChatalHistological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.
000176 (1998) J Barbet (France) ; P Peltier ; S Bardet ; J P Vuillez ; I Bachelot ; S Denet ; P Olivier ; F Leccia ; B Corcuff ; D Huglo ; C Proye ; E Rouvier ; P Meyer ; J F ChatalRadioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
000228 (1994) A Chetanneau (France) ; J Barbet ; P Peltier ; J M Le Doussal ; A Gruaz-Guyon ; A M Bernard ; I Resche ; E Rouvier ; P Bourguet ; M DelaagePretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
000237 (1993) P Peltier (France) ; J P Dutin ; J F Chatal ; P Fumoleau ; P Bourguet ; J C Liehn ; J P Vuillez ; J Y Hérry ; A LoboguerreroUsefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
000244 (1993) A Faivre-Chauvet (France) ; J F Gestin ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F ChatalIntroduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.
000279 (1990) A Chetanneau (France) ; R P Baum ; P A Lehur ; J C Liehn ; A C Perkins ; R Bares ; P Bourguet ; J Y Herry ; J C Saccavini ; J F ChatalMulti-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
000283 (1990) C Curtet (France) ; J P Vuillez ; G Daniel ; G Aillet ; A Chetanneau ; J Visset ; M Kremer ; P Thédrez ; J F ChatalFeasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody.
000288 (1989) J C Liehn (France) ; P Hannequin ; S Nasca ; D Lebrun ; A Fernandez-Valoni ; J ValeyreImmunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method.
000185 (1997) J P Vuillez (France) ; D Moro ; P Y Brichon ; E Rouvier ; E Brambilla ; J Barbet ; P Peltier ; P Meyer ; R Sarrazin ; C BrambillaTwo-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
000230 (1994) J P Vuillez (France) ; D Moro ; E Brambilla ; P Y Brichon ; G Ferretti ; J C Saccavini ; C BrambillaImmunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
000248 (1993) J M Le Doussal (France) ; A Chetanneau ; A Gruaz-Guyon ; M Martin ; E Gautherot ; P A Lehur ; J F Chatal ; M Delaage ; J BarbetBispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
000258 (1992) J P Vuillez (France) ; P Peltier ; J P Caravel ; A Chetanneau ; J C Saccavini ; J F ChatalImmunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
000266 (1991) J P Vuillez (France) ; P Peltier ; J C Mayer ; F Dubois ; A Chetanneau ; P Fumoleau ; A Bertrand ; J F ChatalReproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
000316 (????) A Hamy (France) ; C Curtet ; J Paineau ; J F Chatal ; J VissetFeasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 steps targetting with bispecific antibody.
000023 (2012) Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-BodéréPhase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000139 (2002) Françoise Kraeber-Bodéré (France) ; Catherine Saï-Maurel ; Loïc Campion ; Alain Faivre-Chauvet ; Eric Mirallié ; Michel Chérel ; Stéphane Supiot ; Jacques Barbet ; Jean-François Chatal ; Philippe ThédrezEnhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
000160 (1999) F Kraeber-Bodéré (France) ; A Faivre-Chauvet ; C Saï-Maurel ; L Campion ; M Fiche ; E Gautherot ; J Le Boterff ; J Barbet ; J F Chatal ; P ThédrezToxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
000166 (1999) E Gautherot (France) ; F Kraeber-Bodéré ; L Daniel ; M Fiche ; E Rouvier ; C Saï-Maurel ; P Thedrez ; J F Chatal ; J BarbetImmunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
000208 (1996) A Devys (France) ; P Thedrez ; E Gautherot ; A Faivre-Chauvet ; C Saï-Maurel ; E Rouvier ; J L Auget ; J Barbet ; J F ChatalComparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
000236 (1993) J Ouzan (France) ; D Metz ; D Jolly ; J C Liehn ; J ElaertsWhat factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction?
000241 (1993) P Peltier (France) ; C Curtet ; J F Chatal ; J M Le Doussal ; G Daniel ; G Aillet ; A Gruaz-Guyon ; J Barbet ; M DelaageRadioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
000245 (1993) J F Gestin (France) ; A Faivre-Chauvet ; R C Mease ; C Sai-Maurel ; P Thédrez ; M Slinkin ; G E Meinken ; S C Srivastava ; J F ChatalIntroduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.
000249 (1993) M A Slinkin (France) ; C Curtet ; A Faivre-Chauvet ; C Sai-Maurel ; J F Gestin ; V P Torchilin ; J F ChatalBiodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
000304 (1987) J C Liehn (France) ; P Hannequin ; S Nasca ; D Lebrun ; A Cattan ; J ValeyreA new approach to image subtraction in immunoscintigraphy: preliminary results.
000313 (????) F Jasanada (France) ; P Urizzi ; J P Souchard ; F Le Gaillard ; G Favre ; F NepveuIndium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization.
000315 (????) Marc Hillairet De Boisferon (France) ; Olivier Raguin ; Cynthia Thiercelin ; Monique Dussaillant ; William Rostène ; Jacques Barbet ; André Pélegrin ; Anne Gruaz-GuyonImproved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014